0 false false false false false false false false false false true false false false false false false No description of principal activity 2023-08-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 11650553 2023-08-01 2024-07-31 11650553 2024-07-31 11650553 2023-07-31 11650553 2022-08-01 2023-07-31 11650553 2023-07-31 11650553 2022-07-31 11650553 bus:Director1 2023-08-01 2024-07-31 11650553 core:WithinOneYear 2024-07-31 11650553 core:WithinOneYear 2023-07-31 11650553 core:ShareCapital 2024-07-31 11650553 core:ShareCapital 2023-07-31 11650553 core:RetainedEarningsAccumulatedLosses 2024-07-31 11650553 core:RetainedEarningsAccumulatedLosses 2023-07-31 11650553 bus:SmallEntities 2023-08-01 2024-07-31 11650553 bus:AuditExempt-NoAccountantsReport 2023-08-01 2024-07-31 11650553 bus:SmallCompaniesRegimeForAccounts 2023-08-01 2024-07-31 11650553 bus:PrivateLimitedCompanyLtd 2023-08-01 2024-07-31 11650553 bus:AbridgedAccounts 2023-08-01 2024-07-31
COMPANY REGISTRATION NUMBER: 11650553
Evac Medical Limited
Filleted Unaudited Abridged Financial Statements
31 July 2024
Evac Medical Limited
Abridged Financial Statements
Year ended 31 July 2024
Contents
Page
Abridged statement of financial position
1
Notes to the abridged financial statements
3
Evac Medical Limited
Abridged Statement of Financial Position
31 July 2024
2024
2023
Note
£
£
Current assets
Debtors
7,779
9,279
Creditors: amounts falling due within one year
17,888
18,788
--------
--------
Net current liabilities
10,109
9,509
--------
-------
Total assets less current liabilities
( 10,109)
( 9,509)
--------
-------
Net liabilities
( 10,109)
( 9,509)
--------
-------
Capital and reserves
Called up share capital
1
1
Profit and loss account
( 10,110)
( 9,510)
--------
-------
Shareholder deficit
( 10,109)
( 9,509)
--------
-------
These abridged financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the abridged statement of income and retained earnings has not been delivered.
For the year ending 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The member has not required the company to obtain an audit of its abridged financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of abridged financial statements .
All of the members have consented to the preparation of the abridged statement of income and retained earnings and the abridged statement of financial position for the year ending 31 July 2024 in accordance with Section 444(2A) of the Companies Act 2006.
Evac Medical Limited
Abridged Statement of Financial Position (continued)
31 July 2024
These abridged financial statements were approved by the board of directors and authorised for issue on 26 April 2025 , and are signed on behalf of the board by:
Mr G M Brooke
Director
Company registration number: 11650553
Evac Medical Limited
Notes to the Abridged Financial Statements
Year ended 31 July 2024
1. General information
The company is a private company limited by shares, registered in England & Wales. The address of the registered office is Midway House, Herrick Way, Staverton Technology Park, Staverton, Cheltenham, GL51 6TQ, UK.
2. Statement of compliance
These abridged financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The abridged financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The abridged financial statements are prepared in sterling, which is the functional currency of the entity.
4. Director's advances, credits and guarantees
As at the year end the company was owed £7,839 (2023 £9,339) by its Director Mr G M Brooke .